249 related articles for article (PubMed ID: 29753343)
1. Rare Diseases: Addressing the Challenges in Diagnosis, Drug Approval, and Patient Access.
Copley-Merriman K
Value Health; 2018 May; 21(5):491-492. PubMed ID: 29753343
[No Abstract] [Full Text] [Related]
2. Regulators adopt more orphan drugs.
Reardon S
Nature; 2014 Apr; 508(7494):16-7. PubMed ID: 24695293
[No Abstract] [Full Text] [Related]
3. Duel over discounts. Pharma, providers at odds over 'orphan drugs'.
Daly R
Mod Healthc; 2012 Jan; 42(4):30-1. PubMed ID: 22359763
[No Abstract] [Full Text] [Related]
4. A personal perspective of orphan drug development for rare diseases: A golden opportunity or an unsustainable future?
Oo C; Rusch LM
J Clin Pharmacol; 2016 Mar; 56(3):257-9. PubMed ID: 26211513
[No Abstract] [Full Text] [Related]
5. Orphanage at the FDA.
Chen E
J Cardiovasc Transl Res; 2012 Oct; 5(5):735-6. PubMed ID: 21080134
[No Abstract] [Full Text] [Related]
6. The Orphan Drug Act Revisited.
Thomas S; Caplan A
JAMA; 2019 Mar; 321(9):833-834. PubMed ID: 30768155
[No Abstract] [Full Text] [Related]
7. Rare diseases, orphan drugs and their regulation: questions and misconceptions.
Tambuyzer E
Nat Rev Drug Discov; 2010 Dec; 9(12):921-9. PubMed ID: 21060315
[TBL] [Abstract][Full Text] [Related]
8. A cross-national comparative study of orphan drug policies in the United States, the European Union, and Japan: towards a made-in-China orphan drug policy.
Liu BC; He L; He G; He Y
J Public Health Policy; 2010 Dec; 31(4):407-20; discussion 420-1. PubMed ID: 21119648
[TBL] [Abstract][Full Text] [Related]
9. FDA program could boost treatments for neglected diseases.
Traynor K
Am J Health Syst Pharm; 2008 Sep; 65(17):1595-6. PubMed ID: 18714098
[No Abstract] [Full Text] [Related]
10. New drugs carry hefty price tags. Makers of leading-edge orphan products asked to cut prices, take smaller profits.
Lee J
Mod Healthc; 2013 Oct; 43(40):14. PubMed ID: 24340725
[No Abstract] [Full Text] [Related]
11. Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage.
Kesselheim AS; Treasure CL; Joffe S
PLoS Med; 2017 Jan; 14(1):e1002190. PubMed ID: 28045970
[TBL] [Abstract][Full Text] [Related]
12. The routes to orphan drug designation--our recent experience at the FDA.
Lev D; Thorat C; Phillips I; Thomas M; Imoisili MA
Drug Discov Today; 2012 Feb; 17(3-4):97-9. PubMed ID: 22210120
[No Abstract] [Full Text] [Related]
13. Delayed access to treatments for rare diseases: who's to blame?
Feltmate K; Janiszewski PM; Gingerich S; Cloutier M
Respirology; 2015 Apr; 20(3):361-9. PubMed ID: 25722183
[TBL] [Abstract][Full Text] [Related]
14. Protein replacement therapies for rare diseases: a breeze for regulatory approval?
Gorzelany JA; de Souza MP
Sci Transl Med; 2013 Mar; 5(178):178fs10. PubMed ID: 23536010
[TBL] [Abstract][Full Text] [Related]
15. Rare-disease drugs to receive consideration on par with serious-disease drugs.
Thompson CA
Am J Health Syst Pharm; 2012 Nov; 69(22):1936-7. PubMed ID: 23135552
[No Abstract] [Full Text] [Related]
16. [Orphan drugs: drugs for rare diseases].
Schenk M
Dtsch Med Wochenschr; 2010 May; 135(18):p17. PubMed ID: 20455291
[No Abstract] [Full Text] [Related]
17. Raising orphans: how clinical development programs of drugs for rare and common diseases are different.
Orfali M; Feldman L; Bhattacharjee V; Harkins P; Kadam S; Lo C; Ravi M; Shringarpure DT; Mardekian J; Cassino C; Coté T
Clin Pharmacol Ther; 2012 Aug; 92(2):262-4. PubMed ID: 22739137
[TBL] [Abstract][Full Text] [Related]
18. Medicines for rare (orphan) diseases: an enquiry and proposal for tax-incentives.
John JE
Drug Discov Today; 2011 Dec; 16(23-24):999-1000. PubMed ID: 22020052
[No Abstract] [Full Text] [Related]
19. Adoption agents.
Wapner J
Sci Am; 2010 Jun; 302(6):19-20. PubMed ID: 20521471
[No Abstract] [Full Text] [Related]
20. Accessing the accelerated approval pathway for rare disease therapeutics.
Kakkis ED; Kowalcyk S; Bronstein MG
Nat Biotechnol; 2016 Apr; 34(4):380-3. PubMed ID: 27054988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
